He also presented published and unpublished findings on the identification of MAPK1 mutations as a new event underlying a novel RASopathy and on the identification of a second form of recessive NS resulting from biallelic LOF variants in SPRED2 (Motta et al., 2020, 2021). The gene discussed is MAPK1; the disease is RASopathy.